Aster Dm Healthcare Ltd. · NSE:ASTERDM
Aster Dm Healthcare — Q3 FY23 Earnings Presentation
56 slides from Aster Dm Healthcare's earnings presentation, Feb 14, 2023
Slide 1: Exchange filing cover letter
February 14, 2023 The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd 1st Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Bandra (East), Mumbai 40005
Slide 2: Investor Presentation for the quarter ended 31st December 2022
Aster &; We'll Treat You Well INVESTOR PRESENTATION For the quarter ended 31st December 2022
Slide 3: Disclaimer
Disclaimer * This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other condit
Slide 4: Vision
VISION A Caring Mission with a Global Vision to Serve the World with Accessible and Affordable Quality Healthcare.
Slide 5: Aster DM Healthcare – Evolution
Aster DM Healthcare – Evolution New geographies, segments Brand “Aster” was formed, private Robust Growth across all Growth and Diversification into Building the foundations and service offerings equity investment, further expansion segments and geographies; Rapid aligned businesses across Expansion
Slide 6: Business Overview (9M)
Business Overview (9M) 30 GCC : 15 Largest Private Healthcare 5,536 GCC : 1,441 Hospitals India : 15 Capacity Beds India : 4,095 Presence in 7 Countries 125 GCC : 113 14.6 Mn GCC. : 12.4 Mn Clinics India : 12 Patient Visits India : 2.2 Mn4 496 GCC : 257 Pharmacies1 India : 2392 Largest Number of Med
Slide 7: Geographical Footprint
6 Geographical Footprint United Arab Emirates Kingdom of Saudi Arabia Kerala Andhra Pradesh Karnataka H(9) C(99) P(234) H(1) H(6) C(2) P(72) L(5) PEC(82) H(4) C(4) L(2) P(2) PEC(2) H(3) C(6) P(105) L(6) PEC(68) Oman Qatar Bahrain Jordan Maharashtra Telangana Tamil Nadu C(2) P(2) H(1) L(3) PEC(4) H(1
Slide 8: Aster DM Healthcare – Financial Overview
Aster DM Healthcare – Financial Overview
Slide 9: GCC Hospitals
GCC Hospitals 8 UAE Qatar Oman Saudi
Slide 10: India Hospitals
India Hospitals 9 Kerala Cluster Andhra & Telangana Cluster Karnataka & Maharashtra Cluster
Slide 11: Hospitals: Pipeline Projects
Hospitals: Pipeline Projects Owned / Hospitals - GCC Location Planned Beds Expected Completion Year Present Status Leased/O&M Owned / Hospitals - India Location Planned Beds Expected Completion Year Present Status Leased/O&M
Slide 12: The Aster DM Healthcare Edge
The Aster DM • Healthcare Edge • Robust & • • Expansive Healthcare • Ecosystem • Synergies • • Across Geographies Sturdy • • Performance Record • • Proficient & Experienced • Management • Team Asset-Light Business Model • • De-Risked Business Model • • Touchstone of • Healthcare • Practices
Slide 13: Historical Trends
Historical Trends Capacity Beds Outpatient Count (in mn) Inpatient Count (in ‘000) ..Coupled with capacity creation for further growth # of Units FY17 FY18 FY19 FY20 FY21 FY22 FY23 9M Hospitals 18 19 24 25 27 27 30 Clinics 96 101 114 117 115 120 125 Pharmacies - GCC 202 207 219 238 223 240 257 Pharm
Slide 14: An Integrated Healthcare Provider
AN INTEGRATED HEALTHCARE PROVIDER Aster – An Integrated Healthcare Provider
Slide 15: Aster - An Integrated Healthcare Provider
Aster - An Integrated Healthcare Provider FY22 Operational Information 1,500+ 273,000+ Cardiovascular IP Discharges Surgeries ~6.2 mn 20,500+ 1,300+ Clinic OPD Visits General Bariatric Surgeries Surgeries 2,400+ 800+ Joint ~ 8.0 mn Spine Replacements Pharmacy Surgeries Visits 13,600+ 500+ Urology Ca
Slide 16: Aster – A Healthcare Ecosystem
Aster – A Healthcare Ecosystem Patient Life Cycle Management • Hospitals Clinics Pharmacies • • GCC INDIA • • Hospitals Clinics Resource Talent Management
Slide 17: Digital Health
Digital Health Doctor Video Consultation From Anywhere Book Appointments Express Delivery Explore The Widest Range Manage Health Records In-Person And Online Within 90 Min Of Wellness Products For Your Family And You Aster Virtual Care - Omni-channel experience for Patients = Current active user bas
Slide 18: Origin, Legacy, Footprint, Portfolio, Profitability
ORIGIN LEGACY FOOTPRINT PORTFOLIO PROFITABLITY
Slide 19: GCC Healthcare – Unique traits
GCC Healthcare – Unique traits Prevalence of Primary and Secondary Healthcare Facilities (Private Sector) ➢ ➢ ➢ ➢ ➢ Seasonality of Patient Volumes ➢ ➢ ➢ ➢ ➢ Source : World Bank (2021 data) ➢ Source: 1. english.alarabiya.net ➢ 2. worldpopulationreview.com 3. omanobserver.com 4. edsfze.com
Slide 20: Forward (India)
(INDIA) ◼ Current Status ◼ ◼ ◼ ◼ ◼ Forward Way ◼ ◼ *239 pharmacies in India operated by ARPPL under brand license from Aster
Slide 21: Aster - Awards & Service Excellence
Aster - Awards & Service Excellence 20 Dr. Azad Moopen • Alisha Moopen • • • • • • • • • • Accreditation from 6 JCI Accredited DNV Accreditation – European Society of Aster Hospital Mankhool, Orthopaedics Centre of Medical Oncology Qusais and Day Care “Saudi Central Board for Excellence Surgery Cent
Slide 22: Aster - Awards
Aster - Awards Times All India Multispecialty Outlook's Best Hospital Ranking UAE Innovation Award Hospitals Ranking Survey 2021 2022 Dubai Quality Award IHF LinkedIn Aster Top 5 DQA - DQAA Dubai Service Excellence ICC Healthcare Excellence Awards The Economics Times Healthcare Awards Aster No.155 F
Slide 23: Aster - Awards
Aster - Awards Asian Hospital Cyber Security Council Middle East Technology Management Awards Excellence Awards Arabia Corporate Social Excellence in therapeutic food World AI Show & Awards – Responsibility Awards service management Best Project Implementation (AI Case Award) Aster Medcity, National
Slide 24: Operational and Financial Overview
OPERATIONAL AND FINANCIAL OVERVIEW Operational and Financial Overview
Slide 25: Clinical Highlights - FY23 Q3
Clinical Highlights - FY23 Q3 India ➢ ➢ ➢ ➢ ➢ GCC ➢ ➢ ➢ ➢ ➢
Slide 26: Revenue and Profitability Snapshot – FY23 Q3
Revenue and Profitability Snapshot – FY23 Q3 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) ▪ Revenue excluding new hospitals4 is Rs. ▪ EBITDA excluding new hospitals4 is Rs. ▪ PAT (Post-NCI) excluding new hospitals4 3,161 Crs. (Growth of 19 %) 468 Crs. (Growth of 15%, EBITDA Mar
Slide 27: Revenue and Profitability Snapshot – FY23 9M
Revenue and Profitability Snapshot – FY23 9M Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) ▪ Revenue excluding new hospitals4 is ▪ EBITDA excluding new hospitals4 is Rs. ▪ PAT (Post-NCI) excluding new Rs. 8,611 Crs. (Growth of 14 %) 1,123 Crs. (Growth of 9 %, EBITDA hospitals an
Slide 28: Geography-wise Financial Snapshot – Quarterly
Geography – wise Financial – Snapshot – Quarterly GCC INDIA CONSOLIDATED FY22 Q3 FY23 Q3 Gw (%) FY22 Q3 FY23 Q3 Gw (%) FY22 Q3 FY23 Q3 Gw (%) Revenue (₹) EBITDA (₹) PAT (Post-NCI) (₹) ➢ ➢ ➢ ➢
Slide 29: Geography-wise Financial Snapshot – YTD
Geography – wise Financial – Snapshot – YTD GCC INDIA CONSOLIDATED FY22 9M FY23 9M Gw (%) FY22 9M FY23 9M Gw (%) FY22 9M FY23 9M Gw (%) Revenue (₹) EBITDA (₹) PAT (Post-NCI) (₹) ➢ ➢ ➢ ➢
Slide 30: Geography-wise Business Snapshot - Quarterly
Geography – wise Business – Snapshot - Quarterly GCC INDIA CONSOLIDATED FY22 Q3 FY23 Q3 FY22 Q3 FY23 Q3 FY22 Q3 FY23 Q3 Total Capacity Beds Operational Beds (Census) Operational Beds (Non-Census) Available Capacity Beds ALOS (Days) Occupancy Outpatient Visits In-patient visits ARPOBD (INR)
Slide 31: Geography-wise Business Snapshot – YTD
Geography – wise Business – Snapshot – YTD GCC INDIA CONSOLIDATED FY22 9M FY23 9M FY22 9M FY23 9M FY22 9M FY23 9M Total Capacity Beds Operational Beds (Census) Operational Beds (Non-Census) Available Capacity Beds ALOS (Days) Occupancy Outpatient Visits In-patient visits ARPOBD (INR)
Slide 32: Geography-wise Business Snapshot – Quarterly
Geography – wise Business – Snapshot – Quarterly KARNATAKA & ANDHRA & KERALA TOTAL MAHARASHTRA TELANGANA FY22 Q3 FY23 Q3 FY22 Q3 FY23 Q3 FY22 Q3 FY23 Q3 FY22 Q3 FY23 Q3 Total Capacity Beds Operational Beds (Census) Operational Beds (Non-Census) Available Capacity Beds ALOS (Days) Occupancy Outpatien
Slide 33: Geography-wise Business Snapshot – YTD
Geography – wise Business – Snapshot – YTD KARNATAKA & ANDHRA & KERALA TOTAL MAHARASHTRA TELANGANA FY22 9M FY23 9M FY22 9M FY23 9M FY22 9M FY23 9M FY22 9M FY23 9M Total Capacity Beds Operational Beds (Census) Operational Beds (Non-Census) Available Capacity Beds ALOS (Days) Occupancy Outpatient Visi
Slide 34: Segmental Performance FY23 Q3 and growth rates
Growth rates India - India - Labs Unallocated India - India - Labs Unallocated GCC GCC GCC GCC FY23 Q3 GCC Clinics Hospitals & & Wholesale & Total GCC Clinics Hospitals & & Wholesale & Total Hospitals Pharmacies Hospitals Pharmacies Clinics Pharmacy Eliminations Clinics Pharmacy Eliminations No. of
Slide 35: Segmental Performance FY23 9M
Segmental Performance FY23 9M Growth rates India - Labs India - Labs India - Unallocated India - Unallocated GCC GCC & GCC GCC & FY23 9M GCC Clinics Hospitals & & Total GCC Clinics Hospitals & & Total Hospitals Pharmacies Wholesale Hospitals Pharmacies Wholesale Clinics Eliminations Clinics Eliminat
Slide 36: Maturity Wise Hospital Performance – GCC FY23 9M
Maturity Wise Hospital Performance – GCC FY23 9M ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹
Slide 37: Maturity Wise Hospital Performance – India FY23 9M
Maturity Wise Hospital Performance – India FY23 9M ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹
Slide 38: Financial Summary – Profitability Statement (1/2)
Financial Summary – Profitability Statement (1/2) As at Mar 31, As at Dec 31, Particulars (INR Cr) FY23 Q2 FY22 Q3 FY23 Q3 Y-o-Y Gw% Q-o-Q Gw% Consolidated (INR Cr) 2022 2022 Revenue from operations 2,816 2,650 3,192 20% 13% Gross Debt 2,192 2,465 Less: Cash, Bank Balance and Current Investments 386
Slide 39: Financial Summary – Profitability Statement (2/2)
Financial Summary – Profitability Statement (2/2) Particulars (INR Cr) FY22 9M FY23 9M Gw% Revenue from operations 7,525 8,671 15% Material consumption 2,188 2,605 Doctors cost 1,509 1,826 Employee cost (excl. doctors) 1,486 1,898 Laboratory outsourcing charges 200 55 Other expenses 1,122 1,227 EBIT
Slide 40: Consol Trends - I
Consol Trends - | 39 Revenue (INR Cr) EBITDA 10,253 1,483 1,258 8,652 8,608 i 1,063 ; FY20 Fy21 FY22 FY23 9M FY20 FY21 FY22 FY23 9M EBITDA Margin ROCE 9.7% 8.5% 14.5% 14.5% —s99% 7.A% [PY 9m: 13.6%] 5.1% FY20 FY21 FY22 FY23 9M FY20 FY21 FY22 FY23 TTM EBITDA numbers are Post IndAS116 FY21 numbers hav
Slide 41: Consol Trends - II
Consol Trends - Il Net Debt (excl. Lease Liabilities) (INR Cr) 2,784 2,004 2,132 1,806 FY20 FY21 FY22 FY23 9M 40 Net Debt (incl. Lease Liabilities) (INR Cr) 5,416 5,111 4,498 4,521 FY20 FY21 FY22 FY23 9M Net Debt (excl. Lease Liabilities)/EBITDA 2.9 27 1.6 19 FY20 Fy21 FyY22 FY23TTM * Post IndAS 116
Slide 42: India: Financial Trends
India: Financial Trends Revenue EBITDA 2384 353 1631 1654 183 144 FY20 Fy21 FY22 FY23 9M FY20 FY21 FY22 FY23 9M EBITDA Margin ROCE 15.0% 14.8% (PY 9M:15.5%) 8.2% 7.2% 11.3% 8.7% 1.6% 0.0% FY20 Fy21 FY22 FY23 9M FY20 FY21 FY22 FY23 TTM at
Slide 43: India Hospital & Clinics Cluster-Wise Trends
India Hospital & Clinics Cluster-Wise Trends
Slide 44: Strategy & Leadership
STRATEGY & LEADERSHIP Strategy & Leadership
Slide 45: GCC Strategy
GCC Strategy The pandemic allowed us to reflect and re- invent certain processes at all the locations. Enhanced use of digital means made us explore the power of digitization. We have launched Aster Digital Initiative with a strong focus on foundational and growth levers. Initiatives like Virtual Ca
Slide 46: India Strategy
India Strategy Aster DM Hospitals consistently amongst the top in google rankings and patient endorsements – Visibly growing appreciation in India for quality healthcare, clinical excellence and patient service
Slide 47: ESG: Committed to UN Sustainable Development Goals
ESG: Committed to UN Sustainable Development Goals
Slide 48: ESG highlights for the year
ESG highlights for the year In this financial year we have made significant progress on all aspects of E: Environment, S: Social and G: Governance performance 1,993 MWh energy consumption reduction n x across Aster Hospitals GCC fg 268,983 KL of water saved by recycling Environment a2 100% Resolutio
Slide 49: Aster’s ESG Materiality Assessment
Aster’s ESG Materiality Assessment
Slide 50: Aster’s commitment to UNSDG
Aster’s commitment to UNSDG The 17 Sustainable Development Goals are considered as the blueprint to achieve a sustainable future for all, it is important that we all work together to achieve them by 2030. At Aster, we have identified the goals relevant to our operations, and we are working towards t
Slide 51: Aster’s alignment with SASB to focus on material issues
Aster’s alignment with SASB to focus on material issues
Slide 52: Aster DM Healthcare - ESG update under each pillar
Aster DM Healthcare - ESG update under each pillar ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪
Slide 53: Aster – ESG Strategy
Aster – ESG Strategy Current ESG practices External engagement for gap ESG Policy and ESG Risk ESG Pillars identified in assessment of Aster’s framework approved by the Board level ESG commitment Sustainability Report Aster Board sustainability report against global frameworks Next steps ▪ ▪ ▪ ▪ ▪ ▪
Slide 54: Aster Leadership Team
Aster Leadership Team Dr. Azad Moopen T. J. Wilson Dr. Malathi Fara Siddiqi Alisha Moopen Veneeth Purushotaman Daniel Whitehead Amitabh Johri Brandon Rowberry Dr. Shanila Laiju Dr. Sherbaz Bichu Bala NS Sunil Kumar M R Farhan Yasin Dr. Nitesh Shetty Devanand K T Rahul Kadavakolu Ravi Lakkoju
Slide 55: Aster Board of Directors
Aster Board of Directors Dr. Azad Moopen Alisha Moopen T. J. Wilson Anoop Moopen Shamsudheen Bin Daniel Robert Emmanuel David Sridar Arvamudhan Mohideen Mammu Haji Mintz Gootam Iyengar Dr. Layla Mohamed Chenayappillil John James Mathew Wayne Earl Hassan Ali Al Marzooqi George Keathley
Slide 56: Thank You
Aster We'll Treat You Well Thank You www.asterdmhealthcare.com Email: investors@asterdmhealthcare.com